All In Biotech

Drug Trial Radar · NCT07186634

PeRiOperative Medicine Platform Trial

Domain-Specific Appendix: OXYGEN

Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 7,800 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

7,800

Planned (sponsor's estimate)

Start

Apr 6, 2026

Primary completion

Dec 2035

Study completion Dec 2035

Sponsor

Lead sponsor
Monash UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The Alfred; Wellington Hospital
First posted
Sep 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Our specific aims are to investigate whether conservative (≤30%), intermediate (50%), or liberal (80%) inspired oxygen during and immediately after surgery: Aim 1: Reduces surgical site infections (SSIs or "wound infections") and other healthcare-associated infections (pneumonia and sepsis). Aim 2: Reduces a pooled composite of serious postoperative complications, leading to a faster and more complete recovery after surgery, and thus increases "days alive and at home up to 30 days after surgery" (DAH30). Primary hypothesis: Liberal (80%) oxygen concentration delivered with anesthesia in patients undergoing major surgery reduces the incidence of SSIs after surgery compared to conservative (≤30%) or intermediate (50%) oxygen concentration. Secondary hypothesis: Hyperoxia (50-80%) delivered with anesthesia in patients undergoing major surgery increases the incidence of pulmonary and other complications after surgery compared to conservative (≤30%) oxygen concentration, resulting in fewer Days At Home (DAH). PROMPT enrolls patients undergoing elective or semi-elective surgery.

Conditions

  • Surgical Site Infection After Major Surgery
  • Anaesthesia
  • Major Complications
  • Quality of Recovery (QoR-15)
  • Quality of Life

Interventions

  • Liberal inspired oxygenDrug

    The concentration of Oxygen will differ according to the randomisation

  • Conservative inspired oxygenDrug

    Conservative inspired oxygen

  • Intermediate inspired oxygenDrug

    Intermediate inspired oxygen

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Surgical Site InfectionTime frame: 30 days

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • The Alfred

    Melbourne, Victoria, Australia · Recruiting

  • Wellington Hospital

    Wellington, NZ, New Zealand · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.